|
|
|
|
|
|
by elipsey
3323 days ago
|
|
|
Article argues that patent evergreening necessitated dishonest marketing and resulted in a "created market" type of strategy. The patent for OxyContin was predicated on the claim that each dose lasted longer than older poducts. When that didn't work they raised the dose instead of shortening dosing intervals, which caused a reward/withdrawal cycle in patients. |
|
|